Gita Thanarajasingam

Hematology | Oncology
200 1st St SW
Rochester, MN 55905

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 103 publications

Erratum: High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis.

Erratum: High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 27, 2026

Illustrative Integration of Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Data in Dose-Cohort Review for a Phase I Clinical Trial.

Illustrative Integration of Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Data in Dose-Cohort Review for a Phase I Clinical Trial.

Journal: Research square
Published: July 10, 2026

High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis.

High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 11, 2026

Improved overall survival in classical Hodgkin lymphoma across therapeutic eras: A National Cancer Database study.

Improved overall survival in classical Hodgkin lymphoma across therapeutic eras: A National Cancer Database study.

Journal: British journal of haematology
Published: June 10, 2026

Psychometric Evaluation of the PRO-CTCAE Average Composite Score: Reliability, Responsiveness, Known-Groups Validity, and Sensitivity to Group Differences.

Psychometric Evaluation of the PRO-CTCAE Average Composite Score: Reliability, Responsiveness, Known-Groups Validity, and Sensitivity to Group Differences.

Journal: Cancers
Published: May 27, 2026

Benefits of Electronic Symptom Monitoring During Cancer Treatment by Age, Sex, Race, and Education (Alliance AFT-39).

Benefits of Electronic Symptom Monitoring During Cancer Treatment by Age, Sex, Race, and Education (Alliance AFT-39).

Journal: JCO oncology practice
Published: May 12, 2026

Beyond maximum grade: key regulatory considerations in adverse event reporting.

Beyond maximum grade: key regulatory considerations in adverse event reporting.

Journal: The Lancet. Haematology
Published: March 13, 2026

Survival trends in the era of novel therapies identify unmet needs in peripheral T-cell lymphoma: a national cancer database analysis.

Survival trends in the era of novel therapies identify unmet needs in peripheral T-cell lymphoma: a national cancer database analysis.

Journal: Blood cancer journal
Published: March 10, 2026

Beyond maximum grade: long-term toxicity and survivorship in haematological malignancies.

Beyond maximum grade: long-term toxicity and survivorship in haematological malignancies.

Journal: The Lancet. Haematology
Published: February 20, 2026

Beyond maximum grade: the role of real-world digital health technologies to capture, predict, and manage treatment toxicity in haematological cancers.

Beyond maximum grade: the role of real-world digital health technologies to capture, predict, and manage treatment toxicity in haematological cancers.

Journal: The Lancet. Haematology
Published: February 18, 2026

A single item for overall side effect impact: Association with clinician-reported adverse events and global health.

A single item for overall side effect impact: Association with clinician-reported adverse events and global health.

Journal: Clinical trials (London, England)
Published: January 06, 2026

Experience DOM35: The 2035 Vision for the Mayo Clinic Future Department of Medicine.

Experience DOM35: The 2035 Vision for the Mayo Clinic Future Department of Medicine.

Journal: Mayo Clinic proceedings
Published: October 01, 2025
Showing 1-12 of 103

Last Updated: 09/26/2026